Your session is about to expire
← Back to Search
S. sonnei 53G for Shigellosis
Study Summary
This trial will compare the rate of shigellosis in people who have been previously infected with a different strain of Shigella to the rate of infection in people who have not been infected before.
- Shigellosis
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- Group 1: Group 2B: S. sonnei 53G
- Group 2: Group 1A: S. sonnei 53G
- Group 3: Group 1B: S. flexneri 2a 2457T
- Group 4: Group 2A: S. flexneri 2a 2457T (1500 cfu)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are investigators currently recruiting for this trial?
"The trial is still recruiting participants and the particulars are listed on clinicaltrials.gov, with an initial posting date of April 26th 2022 and a final edit date of April 18th 2022."
How many individuals have been inducted into the research project thus far?
"Indeed, clinicaltrials.gov confirms that the clinical trial is actively recruiting participants since it was first published on April 26th 2022 and last updated on April 18th 2022. 80 patients are being recruited through a single site for this study."
Has the Food and Drug Administration approved S. sonnei 53G?
"The limited data available on S. sonnei 53G's efficacy and safety merit a score of 1 when assessing its risk profile."
What criteria must participants satisfy to join this medical trial?
"80 patients of ages 18 to 50, who have been diagnosed with shigellosis, are eligible for admittance in this trial."
Do participants of this research study need to be under 40 years old?
"The requirements for enrollment in this trial specify that the minimum age is 18, while participants must not exceed 50 years old."
Share this study with friends
Copy Link
Messenger